Bristol-Myers Shares Drop on No Deal Talks With AstraZeneca
Bristol-Myers Squibb premarket stock declines 1.4% after reports confirm no discussions with AstraZeneca on a potential deal. Bristol-Myers Squibb (BMY) fell 1.4% in premarket trading following a report that no discussions are underway with AstraZeneca (AZN) regarding a po